These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

803 related items for PubMed ID: 18163519

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
    Bartoloni E, Alunno A, Bistoni O, Bizzaro N, Migliorini P, Morozzi G, Doria A, Mathieu A, Lotzniker M, Allegri F, Riccieri V, Alpini C, Gabrielli A, Tampoia M, Gerli R, Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) investigators.
    Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488
    [Abstract] [Full Text] [Related]

  • 5. A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis.
    Svärd A, Kastbom A, Söderlin MK, Reckner-Olsson Å, Skogh T.
    J Rheumatol; 2011 Jul; 38(7):1265-72. PubMed ID: 21459947
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients.
    Zhu T, Feng L.
    Int J Rheum Dis; 2013 Apr; 16(2):157-61. PubMed ID: 23773638
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z, Palafox-Sánchez CA, Parra-Rojas I, Martínez-Bonilla GE, del Toro-Arreola S, Ramírez-Dueñas MG, Ocampo-Bermudes G, Muñoz-Valle JF.
    Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
    [Abstract] [Full Text] [Related]

  • 10. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
    van Heemst J, Trouw LA, Nogueira L, van Steenbergen HW, van der Helm-van Mil AH, Allaart CF, Serre G, Holmdahl R, Huizinga TW, Toes RE, van der Woude D.
    Arthritis Res Ther; 2015 Oct 05; 17():276. PubMed ID: 26437716
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis.
    Dejaco C, Klotz W, Larcher H, Duftner C, Schirmer M, Herold M.
    Arthritis Res Ther; 2006 Oct 05; 8(4):R119. PubMed ID: 16859519
    [Abstract] [Full Text] [Related]

  • 14. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L, Szekanecz Z, Szabó Z, Fekete A, Zeher M, Horváth IF, Dankó K, Kapitány A, Végvári A, Sipka S, Szegedi G, Lakos G.
    J Rheumatol; 2007 Aug 05; 34(8):1658-63. PubMed ID: 17611988
    [Abstract] [Full Text] [Related]

  • 15. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH.
    Arthritis Rheum; 2009 Aug 05; 60(8):2232-41. PubMed ID: 19644872
    [Abstract] [Full Text] [Related]

  • 16. Association of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide.
    El-Barbary AM, Kassem EM, El-Sergany MA, Essa SA, Eltomey MA.
    J Rheumatol; 2011 May 05; 38(5):828-34. PubMed ID: 21362765
    [Abstract] [Full Text] [Related]

  • 17. Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis.
    Koivula MK, Heliövaara M, Rissanen H, Palosuo T, Knekt P, Immonen H, Risteli J.
    Ann Rheum Dis; 2012 Oct 05; 71(10):1666-70. PubMed ID: 22419777
    [Abstract] [Full Text] [Related]

  • 18. Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis.
    Wagner E, Skoumal M, Bayer PM, Klaushofer K.
    Rheumatol Int; 2009 Sep 05; 29(11):1315-21. PubMed ID: 19184032
    [Abstract] [Full Text] [Related]

  • 19. [Significance and diagnostic value of synovial fluid anti-cyclic citrullinated peptide antibody and anti-mutated citrullinated vimentin antibodies in patients with serum negative rheumatoid arthritis].
    Qu SJ, Ye H, Jia RL, Li ZG.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec 18; 48(6):933-936. PubMed ID: 27987492
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic value of the anti-Sa antibody compared with the anti-cyclic citrullinated peptide antibody in rheumatoid arthritis.
    Iwaszkiewicz C, Puszczewicz M, Białkowska-Puszczewicz G.
    Int J Rheum Dis; 2015 Jan 18; 18(1):46-51. PubMed ID: 25488711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.